CDEK
← All organizations
UroGen Pharma

UroGen Pharma

For profitWebsite ↗

Also known as: iklein@urogen.com | UroGen-Parma LTD | UroGen Pharma | UROGEN PHARMA | UroGen Pharma Ltd.

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 3

First clinical trial

Jun 30, 2013

First marketed drug

Apr 15, 2020

Last known activity

Jun 12, 2025

Timeline

2000s

  1. Jan 1, 2004

    UroGen Pharma— Founded

2010s

  1. Jan 1, 2015

    Telormedix SA— Acquired

2020s

  1. Apr 15, 2020

    mitomycin— Marketing Organization

  2. Apr 15, 2020

    mitomycin— NDA Secondary Org

Drugs by trial phase (5 distinct, 15 trials)

Phase 3 (1 own, 0 via acquisition)

Phase 2 (1 own, 1 via acquisition)

Phase 1 (1 own, 0 via acquisition)

Other trials (1 own, 0 via acquisition)

Indications

Studied for

Marketed drugs (1)

Subsidiaries (1 direct, 1 total across the full acquisition tree)

Recent trials (22)

Details

Founded
New York, NY, US Jan 1, 2004
Last known activity
Jun 12, 2025